Table 2 Differentially expressed miRNAs in Parkinson’s disease compared to controls.
From: Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
miRNAs | Ct value | Fold change | p Value |
|---|---|---|---|
miR-432-5p* | 31 | 3.4 | 0.028 |
miR-23a-5p | 32 | 3.39 | 0.047 |
miR-133b* | 28 | 3.28 | 0.041 |
miR-3177-3p | 35 | 3.27 | 0.0018 |
miR-320a* | 23 | 3.03 | 0.024 |
miR-320b | 25 | 2.95 | 0.017 |
miR-625-5p | 31 | 2.95 | 0.017 |
miR-491-5p | 32 | 2.95 | 0.04 |
miR-4454* | 23 | 2.82 | 0.028 |
miR-221-3p* | 24 | 2.8 | 0.05 |
miR-30d-3p | 34 | 2.62 | 0.049 |
miR-320c | 24 | 2.57 | 0.026 |
miR-324-5p | 29 | 2.56 | 0.049 |
miR-625-3p | 32 | 2.53 | 0.037 |
miR-339-3p | 31 | 2.53 | 0.044 |
miR-130b-3p | 29 | 2.5 | 0.02 |
miR-320d | 24 | 2.49 | 0.032 |
miR-548a-3p | 34 | 2.43 | 0.026 |
miR-627-5p* | 33 | 2.27 | 0.016 |
miR-1260b | 26 | 2.26 | 0.0017 |
miR-185-5p | 24 | 2.24 | 0.047 |
miR-503-5p | 32 | 2.22 | 0.011 |
miR-210-3p | 30 | 2.18 | 0.041 |
miR-197-3p | 28 | 2.16 | 0.049 |
miR-4286 | 26 | 2.1 | 0.002 |
miR-4306 | 30 | 1.9 | 0.031 |
miR-92b-3p | 31 | 1.75 | 0.046 |
miR-3621 | 26 | 1.69 | 0.046 |
miR-3972 | 34 | 1.6 | 0.046 |
miR-1538 | 34 | 1.51 | 0.0009 |
miR-205* | 34 | 0.62 | 0.032 |
miR-10b-5p | 31 | 0.53 | 0.048 |
